Author

Ross Elli

OPTIMISING POST-OPERATIVE CROHN’S DISEASE MANAGEMENT: BEST DRUG THERAPY ALONE VERSUS ENDOSCOPIC MONITORING WITH TREATMENT STEP-UP. THE POCER STUDY

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

SMOKING IS THE KEY RISK FACTOR THAT DOUBLES THE RISK OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE DESPITE PREVENTIVE DRUG TREATMENT. RESULTS FROM THE POCER STUDY

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

STRATEGIC TIMING OF ANTI-TNF THERAPY IN POSTOPERATIVE CROHN’S DISEASE: COMPARISON OF ROUTINE USE IMMEDIATELY POSTOPERATIVELY WITH SELECTIVE USE AFTER DEMONSTRATED RECURRENCE AT 6 MONTH ENDOSCOPY. RESULTS FROM POCER

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

Item 1 - 3 / 4
1